Accelerating Lung Cancer Diagnosis: Label-Free Pathology Through Deep Learning

MedAI Digest
MedAI Digest
Accelerating Lung Cancer Diagnosis: Label-Free Pathology Through Deep Learning
Loading
/

Researchers have developed a label-free method using autofluorescence imaging and deep learning to diagnose non-small cell lung cancer subtypes without conventional tissue staining, achieving expert-validated accuracy while reducing diagnostic time and costs.

Original paper: Label-free pathological subtyping of non-small cell lung cancer using deep classification and virtual immunohistochemical staining. — NPJ digital medicine. 10.1038/s41746-026-00356-1

📄 Read the article

Trending now

Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease.
APOE Genotype and Protein Pathology Shape Dementia Risk in Lewy Body Disease
Transfer-learning guided design of high-performance conjugated polymers for low-voltage electrochemical transistors.
Machine Learning Accelerates Discovery of Ultra-Low-Voltage Polymers
Soft multiclass feature augmented deep learning to predict tumor origins using cytology or histology whole slide images.
AI Identifies Tumor Origins from Tissue Images with 98% Accuracy
AI-guided multi-omics analysis identifies NPC1-modulated susceptibility to SARS-CoV-2 infection under PM2.5 exposure.
Air Pollution and COVID-19: How NPC1 Mediates SARS-CoV-2 Infection Risk